FDA Approval Activities for this Drug…

VIRACEPT (nelfinavir mesylate) Tablets, 625 mg, Agouron NDA 21-503 4/30/03 VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-779/S41 20-778/S20 & 21-503/S2 8/22/03 8/28/03 8/28/03 VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-779/S22 4/23/03 VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-778/S18 & 20-779/S39 12/20/02 7/30/03 4/4/03 VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-778/S16, 20-778/S17, 20-779/S37 & 20-779/S38 2/5/02 4/17/02 VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-778/S14, 20-779/S32 VIRACEPT (nelfinavir mesylate) Tablets and Oral Powder, Pfizer Inc. Viracept (nelfinavir mesylate) 250 mg tablets, Pfizer Viracept (nelfinavir mesylate) 625 mg tablets, Pfizer Viracept (nelfinavir mesylate) oral powder, Pfizer

For the latest approval information, please see the main page.